Skip to main content

Dobmeier Eric

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists Dobmeier Eric as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

ATRA Atara Biotherapeutics, Inc.

Director1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 14, 2023 (view filing)6:27 PM ETNov 104 daysDobmeier EricDirectorPPurchase+446.8K$0.2268+$101.3K+383.5%563.3K after

KDNY Chinook Therapeutics, Inc.

President, CEO8 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Apr 26, 2023 (view filing)5:19 PM ETApr 242 daysDobmeier EricPresident, CEOSSale−23.8K$21.58−$513.5K−7.3%302.3K after
Apr 26, 2023 (view filing)5:19 PM ETApr 242 daysDobmeier EricPresident, CEOSSale+1.20K$22.26+$26.7K+0.4%301.1K after
Feb 15, 2023 (view filing)Feb 105 daysLateDobmeier EricPresident, CEOSSale−8.10K$23.75−$192.3K−2.6%301.1K after
Feb 1, 2023 (view filing)8:32 PM ETJan 30-312 daysDobmeier EricPresident, CEOSSale−32.7K$24.58−$803.4K−10.2%289.0K after2 lots
Dec 2, 2022 (view filing)4:26 PM ETDec 11 dayDobmeier EricPresident, CEOSSale−30.0K$22.31−$669.4K−11.0%241.7K after
May 27, 2022 (view filing)May 252 daysDobmeier EricPresident, CEOPPurchase+5.00K$13.03+$65.2K+2.5%205.9K after
Sep 22, 2021 (view filing)Sep 202 daysDobmeier EricPresident, CEOPPurchase+2.00K$12.00+$24.0K+1.9%109.8K after
Aug 19, 2021 (view filing)Aug 18-191 dayDobmeier EricPresident, CEOPPurchase+10.0K$11.82+$118.2K+10.2%107.8K after2 lots